Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
30.62
-2.92 (-8.71%)
At close: Apr 1, 2025, 4:00 PM
30.50
-0.12 (-0.40%)
After-hours: Apr 1, 2025, 7:56 PM EDT

Crinetics Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2016
Period Ending
Apr '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019 - 2016
Market Capitalization
2,8494,7422,3779851,340465
Upgrade
Market Cap Growth
99.50%99.50%141.36%-26.50%188.40%-23.56%
Upgrade
Enterprise Value
1,5473,9321,8746201,151283
Upgrade
Last Close Price
30.6251.1335.5818.3028.4114.11
Upgrade
PS Ratio
2742.204563.69592.26207.881242.806542.73
Upgrade
PB Ratio
2.153.584.413.114.042.75
Upgrade
P/TBV Ratio
3.583.584.413.114.042.75
Upgrade
EV/Sales Ratio
1488.743783.97467.04130.821067.393982.45
Upgrade
Debt / Equity Ratio
0.040.040.100.010.010.03
Upgrade
Asset Turnover
0.000.000.010.010.000
Upgrade
Quick Ratio
22.8322.8312.9212.1720.9616.47
Upgrade
Current Ratio
23.0523.0513.0712.4521.5516.92
Upgrade
Return on Equity (ROE)
-32.02%-32.02%-50.16%-50.57%-42.98%-51.61%
Upgrade
Return on Assets (ROA)
-20.46%-20.46%-28.18%-29.84%-25.19%-29.85%
Upgrade
Return on Capital (ROIC)
-21.53%-21.53%-30.57%-32.02%-26.41%-31.60%
Upgrade
Earnings Yield
-10.47%-6.29%-9.03%-16.65%-8.04%-15.89%
Upgrade
FCF Yield
-8.07%-4.85%-7.20%-11.87%-6.64%-13.39%
Upgrade
Buyback Yield / Dilution
-39.11%-39.11%-11.71%-35.24%-26.24%-25.95%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q